Arcadia Biosciences, Inc. (RKDA)
0.3076
-0.01
(-2.66%)
USD |
NASDAQ |
Sep 25, 16:00
0.29
-0.02
(-5.72%)
After-Hours: 19:59
Arcadia Biosciences Enterprise Value : -3.507M for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | -3.507M |
| September 24, 2026 | -3.489M |
| September 23, 2026 | -3.249M |
| September 22, 2026 | -3.201M |
| September 21, 2026 | -3.218M |
| September 18, 2026 | -3.188M |
| September 17, 2026 | -3.136M |
| September 16, 2026 | -3.174M |
| September 15, 2026 | -3.238M |
| September 14, 2026 | -3.198M |
| September 11, 2026 | -3.238M |
| September 10, 2026 | -3.190M |
| September 09, 2026 | -3.131M |
| September 08, 2026 | -3.152M |
| September 04, 2026 | -3.147M |
| September 03, 2026 | -3.149M |
| September 02, 2026 | -3.066M |
| September 01, 2026 | -3.079M |
| August 31, 2026 | -3.046M |
| August 28, 2026 | -3.022M |
| August 27, 2026 | -3.059M |
| August 26, 2026 | -3.056M |
| August 25, 2026 | -3.109M |
| August 24, 2026 | -3.130M |
| August 21, 2026 | -3.180M |
| Date | Value |
|---|---|
| August 20, 2026 | -3.170M |
| August 19, 2026 | -3.214M |
| August 18, 2026 | -3.260M |
| August 17, 2026 | -3.130M |
| August 14, 2026 | -2.815M |
| August 13, 2026 | -2.935M |
| August 12, 2026 | -2.651M |
| August 11, 2026 | -2.716M |
| August 10, 2026 | -2.756M |
| August 07, 2026 | -2.660M |
| August 06, 2026 | -2.617M |
| August 05, 2026 | -2.644M |
| August 04, 2026 | -2.762M |
| August 03, 2026 | -2.739M |
| July 31, 2026 | -2.814M |
| July 30, 2026 | -2.797M |
| July 29, 2026 | -2.760M |
| July 28, 2026 | -2.804M |
| July 27, 2026 | -2.784M |
| July 24, 2026 | -2.782M |
| July 23, 2026 | -2.821M |
| July 22, 2026 | -2.760M |
| July 21, 2026 | -2.706M |
| July 20, 2026 | -2.732M |
| July 17, 2026 | -2.716M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | 14.37M |
| PMGC Holdings, Inc. | -4.273M |
| Archer-Daniels-Midland Co. | 43.25B |
| Alico, Inc. | 319.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.266M |
| Revenue (Quarterly) | 1.443M |
| Total Expenses (Quarterly) | 7.709M |
| EPS Diluted (Quarterly) | -2.094 |
| Gross Profit Margin (Quarterly) | 43.73% |
| Profit Margin (Quarterly) | -434.2% |
| Earnings Yield | -1.48K% |
| Normalized Earnings Yield | -1199.38 |